WHWK News

Does Whitehawk Therapeutics, Inc. (WHWK) have what it takes to be a top stock pick for momentum investors? Let's find out.

The mean of analysts' price targets for Whitehawk Therapeutics, Inc. (WHWK) points to a 47.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights PR Newswire MORRISTOWN, N.J., Aug. 6, 2026 Phase 1 trials for HWK-007 and HWK-016 continue to enroll; the Phase 1...

Biocytogen (SSE: 688796; HKEX: 02315) and Whitehawk Therapeutics, Inc. (Whitehawk, Nasdaq: WHWK) today announced a global collaboration to develop bispecific antibody-drug conjugates (BsADC). Biocytogen will provide access to up to five bispecific antibodies using its proprietary RenLite platform...

Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC...

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference PR Newswire MORRISTOWN, N.J., May 28, 2026 MORRISTOWN, N.J., May 28, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc.(Nasdaq...

Whitehawk said it has secured rights from Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs.

Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload PR Newswire MORRISTOWN, N.J., May 21, 2026 Agreement with Hangzhou DAC Provides Option for Up...

Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit PR Newswire MORRISTOWN, N.J., May 20, 2026 MORRISTOWN, N.J., May 20, 2026 /PRNewswire/ -- Whitehawk Therapeutics...